Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase Ia trial of APD-811

Trial Profile

A phase Ia trial of APD-811

Phase of Trial: Phase I

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs Ralinepag (Primary)
  • Indications Pulmonary hypertension
  • Focus Adverse reactions
  • Sponsors Arena Pharmaceuticals
  • Most Recent Events

    • 01 Jun 2017 New trial record
    • 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society
    • 16 May 2017 According to an Arena Pharmaceuticals media release, data from this trial will be presented at the American Thoracic Society (ATS) 2017 International Conference.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top